Novocure (NVCR) Adds Timothy J. Scannell to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Novocure Announces Addition to Its Board of Directors
February 8, 2021 4:00 PM ESTTimothy J. Scannell, President and Chief Operating Officer of Stryker Corporation, elected to board of directors
ST. HELIER, Jersey--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) has announced an addition to its board of directors. Timothy J. Scannell, an experienced executive leader, was elected to Novocures board on Feb. 5.
We are extremely pleased to welcome Tim to our board of directors, said Bill Doyle, Novocures Executive Chairman. His extensive and impressive background at Stryker, one of the worlds leading medical technology companies, will provide invaluable guidance as we advance product... More
